66 results
8-K
EX-99.1
HZNP
Horizon Therapeutics Public Ltd Co
3 May 23
Horizon Therapeutics plc Reports First-Quarter 2023 Financial Results
7:06am
sales from existing medicines; impacts of the COVID-19 pandemic and actions taken to slow its spread, including impacts on supplies and net sales
DEFA14A
9ipf7zir6
12 Dec 22
Additional proxy soliciting materials
5:00pm
8-K
EX-99.4
guwu3 wtlmebteftkpf
12 Dec 22
This Announcement Is Being Made Pursuant to Rule 2.7 of the Irish Takeover Rules
7:39am
8-K
EX-99.1
fuy hwd7hodzrv35c0
12 Dec 22
This Announcement Is Being Made Pursuant to Rule 2.7 of the Irish Takeover Rules
7:39am
8-K
EX-99.5
a053r
12 Dec 22
This Announcement Is Being Made Pursuant to Rule 2.7 of the Irish Takeover Rules
7:39am
8-K
EX-99.2
6cj2b7bv
12 Dec 22
This Announcement Is Being Made Pursuant to Rule 2.7 of the Irish Takeover Rules
7:39am
8-K
EX-99.3
j6lc mdza
12 Dec 22
This Announcement Is Being Made Pursuant to Rule 2.7 of the Irish Takeover Rules
7:39am
8-K
nyccppjufu2
12 Dec 22
This Announcement Is Being Made Pursuant to Rule 2.7 of the Irish Takeover Rules
7:39am
8-K
EX-2.1
ip407n0 r8
12 Dec 22
This Announcement Is Being Made Pursuant to Rule 2.7 of the Irish Takeover Rules
7:39am
DEFA14A
c3si69y gb
12 Dec 22
Additional proxy soliciting materials
6:31am
8-K
EX-99.1
sl1za6
2 Nov 22
Results of Operations and Financial Condition
7:06am
8-K
2sp6m62gzepafmf0p
7 Oct 22
Results of Operations and Financial Condition
8:01am
8-K
EX-99.1
41gox fwrri61ymiyq0r
3 Aug 22
Horizon Therapeutics plc Reports Second-Quarter 2022 Financial Results and Revises Full-Year 2022 Net Sales and Adjusted EBITDA Guidance
7:06am